News Transactions under Novozymes’ stock buyback program Please read the full announcement in the attached PDF Attachment 2021_09_Stock_Buybackprogram Continue Reading Previous Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoimmune Disease at the nPOD 13th Annual Scientific MeetingNext Sanofi: Information concerning the total number of voting rights and shares – January 2021 Related Stories News Deveron Announces Closing of Acquisition of Farm Dog News Ellington Financial Declares Common Dividend and Announces Estimated Book Value Per Common Share as of February 28, 2021 News Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Range Resources Corporation (RRC) on Behalf of Investors News CA Healthcare Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing March 9, 2021 News Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Plug Power, Inc. (PLUG) on Behalf of Investors News CIM Commercial Trust Declares Common and Preferred Stock Dividends
